Cargando…

Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire

The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) called Scleroderma HAQ (SHAQ). We performed a validation of the European Portuguese version of SHAQ for patients with SSc. Patients with different forms of SS...

Descripción completa

Detalles Bibliográficos
Autores principales: Genrinho, Inês, Ferreira, Pedro L., Santiago, Tânia, Carones, Adriana, Mazeda, Carolina, Barcelos, Anabela, Beirão, Tiago, Costa, Flávio, Santos, Inês, Couto, Maura, Rato, Maria, Terroso, Georgina, Monteiro, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671070/
https://www.ncbi.nlm.nih.gov/pubmed/37998293
http://dx.doi.org/10.3390/ijerph20227062
_version_ 1785149373213048832
author Genrinho, Inês
Ferreira, Pedro L.
Santiago, Tânia
Carones, Adriana
Mazeda, Carolina
Barcelos, Anabela
Beirão, Tiago
Costa, Flávio
Santos, Inês
Couto, Maura
Rato, Maria
Terroso, Georgina
Monteiro, Paulo
author_facet Genrinho, Inês
Ferreira, Pedro L.
Santiago, Tânia
Carones, Adriana
Mazeda, Carolina
Barcelos, Anabela
Beirão, Tiago
Costa, Flávio
Santos, Inês
Couto, Maura
Rato, Maria
Terroso, Georgina
Monteiro, Paulo
author_sort Genrinho, Inês
collection PubMed
description The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) called Scleroderma HAQ (SHAQ). We performed a validation of the European Portuguese version of SHAQ for patients with SSc. Patients with different forms of SSc from five Hospital Centers were invited. The reliability of the Portuguese SHAQ was evaluated by internal consistency and by test–retest reliability. Content validity was checked by two rheumatologists and by a panel of patients. Construct validity was assessed by structural validity and by known-groups hypothesis tests. Criterion validity was addressed with selected dimensions from the UCLA GIT 2.0, the SF-36v2, and the EuroQoL EQ-5D-5L. A total of 102 SSc patients agreed to participate, 31 of which answered to the retest. HAQ-DI demonstrated high internal consistency reliability (α = 0.866) and SHAQ also showed high test–retest reliability (ICC 0.61–0.95). We evidenced the unidimensionality of all VASs. HAQ-DI scores were worse in males, patients older than 65 years, and individuals with a diffuse form of SSc. Criterion validity was mainly evidenced through the correlation between the HAQ-DI and SF-36v2 physical summary measure (r = −0.688) and EQ-5D-5L index score (r = −0.723). Likewise, the SHAQ overall disease severity VAS was also correlated with SF-36v2 physical summary measure (r = −0.628). Mental score correlations were smaller. With the exception of the Raynaud’s VAS, all the other VASs correlated well with similar clinical variables. This paper provides evidence to demonstrate how reliable and valid the European Portuguese version of SHAQ is, to be used in SSc patients to assess the clinical severity under the perspective of patients.
format Online
Article
Text
id pubmed-10671070
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106710702023-11-14 Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire Genrinho, Inês Ferreira, Pedro L. Santiago, Tânia Carones, Adriana Mazeda, Carolina Barcelos, Anabela Beirão, Tiago Costa, Flávio Santos, Inês Couto, Maura Rato, Maria Terroso, Georgina Monteiro, Paulo Int J Environ Res Public Health Article The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) called Scleroderma HAQ (SHAQ). We performed a validation of the European Portuguese version of SHAQ for patients with SSc. Patients with different forms of SSc from five Hospital Centers were invited. The reliability of the Portuguese SHAQ was evaluated by internal consistency and by test–retest reliability. Content validity was checked by two rheumatologists and by a panel of patients. Construct validity was assessed by structural validity and by known-groups hypothesis tests. Criterion validity was addressed with selected dimensions from the UCLA GIT 2.0, the SF-36v2, and the EuroQoL EQ-5D-5L. A total of 102 SSc patients agreed to participate, 31 of which answered to the retest. HAQ-DI demonstrated high internal consistency reliability (α = 0.866) and SHAQ also showed high test–retest reliability (ICC 0.61–0.95). We evidenced the unidimensionality of all VASs. HAQ-DI scores were worse in males, patients older than 65 years, and individuals with a diffuse form of SSc. Criterion validity was mainly evidenced through the correlation between the HAQ-DI and SF-36v2 physical summary measure (r = −0.688) and EQ-5D-5L index score (r = −0.723). Likewise, the SHAQ overall disease severity VAS was also correlated with SF-36v2 physical summary measure (r = −0.628). Mental score correlations were smaller. With the exception of the Raynaud’s VAS, all the other VASs correlated well with similar clinical variables. This paper provides evidence to demonstrate how reliable and valid the European Portuguese version of SHAQ is, to be used in SSc patients to assess the clinical severity under the perspective of patients. MDPI 2023-11-14 /pmc/articles/PMC10671070/ /pubmed/37998293 http://dx.doi.org/10.3390/ijerph20227062 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Genrinho, Inês
Ferreira, Pedro L.
Santiago, Tânia
Carones, Adriana
Mazeda, Carolina
Barcelos, Anabela
Beirão, Tiago
Costa, Flávio
Santos, Inês
Couto, Maura
Rato, Maria
Terroso, Georgina
Monteiro, Paulo
Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title_full Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title_fullStr Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title_full_unstemmed Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title_short Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire
title_sort validation of the portuguese version of the scleroderma health assessment questionnaire
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671070/
https://www.ncbi.nlm.nih.gov/pubmed/37998293
http://dx.doi.org/10.3390/ijerph20227062
work_keys_str_mv AT genrinhoines validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT ferreirapedrol validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT santiagotania validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT caronesadriana validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT mazedacarolina validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT barcelosanabela validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT beiraotiago validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT costaflavio validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT santosines validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT coutomaura validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT ratomaria validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT terrosogeorgina validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire
AT monteiropaulo validationoftheportugueseversionofthesclerodermahealthassessmentquestionnaire